| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |